Five million euros for interdisciplinary cancer research
Eleven cancer-control research programmes will receive 5 million euros from Technology Foundation STW and the Dutch Cancer Society (KWF Kankerbestrijding). Researchers from Utrecht are involved in five projects and three of those are led from Utrecht. The research programmes are intended to lead to better cancer treatments or better cancer-prevention methods.
What makes this programme unique is that the approved projects will be carried out by teams in which technical and medical researchers will work together with corporations. This combination is intended to result in technological innovations that directly benefit cancer patients.
The following approved projects have include researchers from Utrecht:
TARGETING THE GLIOBLASTOMA MICRO-ENVIRONMENT
Main applicant: Prof. dr. R.M. Schiffelers, Utrecht University
Participants: Utrecht University, University of Twente and two industrial partners
MRI-GUIDED HIGH INTENSITY FOCUSED ULTRASOUND THERAPY FOR PAINFUL BONE METASTASES – PROMETHEUS (PAIN REDUCTION OF METASTASES BY THERMAL ULTRASOUND)
Main applicant: Dr. ir. L.W. Bartels, Utrecht University
Participants: Utrecht University, Eindhoven University of Technology and an industrial partner
INTERVENTIONAL DUCTOSCOPY TO TREAT (PRE)MALIGNANT BREAST DISEASE: THE EVAPORATE STUDY
Main applicant: Dr. A.J. Witkamp, UMC Utrecht
Partners: UMC Utrecht, Delft University of Technology and two industrial partners
DRUG DELIVERY BY SONOPERATION IN CHILDHOOD DIFFUSE INTRINSIC PONTINE GLIOMA AND HIGHGRADE GLIOMA
Main applicant: Prof.dr. G.J.L. Kaspers, VUmc
Participants: VUmc, University of Twente, Utrecht University and an industrial partner
IRON OXIDE NANOPARTICLES FOR LOCALIZATION OF THE SENTINEL NODE AND DETECTION OF METASTATIC LYMPH MODES IN HEAD AND NECK CANCER (IRONNANOLOC)
Main applicant: Dr.ir. B. ten Haken, Universiteit Twente
Participants: University of Twente, Radboud University, UMC Utrecht and three industrial partners
This study is closely related to Utrecht University’s strategic research theme Life Sciences, under the sub-theme of Cancer.